Context: Establishing reference ranges as well as identifying and quantifying the determinants of thyroid function during pregnancy is important for proper clinical interpretation and optimizing research efforts. However, such data are sparse, specifically for triiodothyronine measurements, and most studies do not take into account thyroid antibodies or human chorionic gonadotropin.
T hyroid physiology undergoes major changes during pregnancy, including an increase in thyroxine binding globulin, an increase in thyroid hormone degradation by placental type 3 deiodinase, and stimulation of the thyroid gland by high concentrations of human chorionic gonadotropin (hCG) (1) . Adequate maternal thyroid hormone availability during pregnancy is required for an optimal pregnancy outcome and normal fetal development (1, 2) . Maternal thyroid dysfunction, including subclinical hypothyroidism and hypothyroxinemia, has a prevalence of 2% to 4% and is associated with a higher risk of adverse pregnancy outcomes such as miscarriage, low birth weight, preeclampsia, preterm delivery, lower child IQ, and lower cortex volume (1) .
Considering the major changes in thyroid physiology, pregnancy-specific, population-based thyroid function reference ranges are required to optimally diagnose thyroid diseases in a clinical setting and to perform studies on adverse outcomes (3, 4) . As most reference range studies only had TSH or free T4 (FT4) measurements available (5) (6) (7) (8) , reference ranges for total T4 (TT4), total triiodothyronine (TT3), or free triiodothyronine (FT3) remain largely unknown. Furthermore, although most studies exclude thyroperoxidase antibody (TPOAb)-positive women in accordance with international guidelines (9) , it remains unknown whether additional exclusion of thyroglobulin antibody (TgAb)-positive women affects pregnancy-specific thyroid function reference range calculations.
The identification and quantification of gestational thyroid function determinants are needed to properly study the association of thyroid disease with adverse outcomes, and it may improve the interpretation of thyroid function tests, allowing for a more individual-based approach toward clinical management. Various clinical patient characteristics such as ethnicity, body mass index (BMI), and smoking have been identified as determinants of gestational thyroid function (9) . Based on experimental data, various underlying mechanisms for these associations are plausible, including changes in peripheral deiodinase activity, alterations in thyroid binding proteins, and thyroidal iodine uptake inhibition (10, 11) . However, the translation of experimental findings to human data has been hampered by the fact that most human studies only have TSH and/or FT4 measurements available. In addition, the quantification of the determinant itself could improve our understanding of certain thyroid function determinants. A prominent example of this is smoking, which is hypothesized to affect deiodinase activity and thyroidal iodine uptake (11) (12) (13) . Most human studies that investigated this assessed smoking using questionnaires (14, 15) rather than the serum cotinine concentration, which is a more specific proxy of smoke exposure (16).
In the current study, we therefore aim to establish reference ranges for a full spectrum of thyroid function measurements (TSH, FT4, TT4, FT3, and TT3), explore the role of TgAb, and study determinants of thyroid function during early gestation in a large populationbased cohort of pregnant women in Sweden.
Methods

Study design and participants
This study was embedded in the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy study (SELMA), a prospective, population-based cohort study of mother-child pairs aiming to investigate the effects of early life exposure to environmental toxicants with a focus on endocrinedisrupting chemicals during the pregnancy and infancy period on pregnancy and child health and development. Eligible participants were pregnant women with a gestational age up to 22 weeks who visited the antenatal care centers in the county of Värmland (located in the western part of Sweden) between September 2007 and March 2010. Participating families provided a written consent for participation in the SELMA study and for collecting blood and urine samples. The SELMA study has been approved by the regional ethical committee, Uppsala, Sweden (2007-05-02, Dnr: 2007/062) (17) .
Laboratory measurements
Maternal samples of blood were collected and centrifuged during the routine visits. Serum samples were frozen at 280°C and stored in a biobank at the Central Hospital in Karlstad. Serum TSH, FT4, TT4, FT3, TT3, TPOAbs, and TgAbs were measured using electrochemoluminescence assays (Cobas e601 platform; Roche Diagnostics, Mannheim, Germany) at the Department of Clinical Chemistry, Máxima Medical Center (Veldhoven, Netherlands). Inter-and intra-assay coefficients of variation were 2.1%, 3.5%, 3.8%, 3.8%, and 7.7% for TSH, FT4, TT4, FT3, and TT3, respectively. TPOAb and TgAb concentrations were considered positive if .34 IU/mL or .115 IU/L (manufacturer cutoffs), respectively, and the coefficients of variation were 12.4% and 7.1% for TPOAb at 33 or 100 IU/L, respectively, and 10.9% and 8.6% for TgAb at 76 and 218 IU/L, respectively.
The serum samples were further analyzed for cotinine as a biomarker for exposure to tobacco or nicotine. A detailed description of the method was previously presented by Lindh et al. (18) . Briefly, aliquots of 100 mL serum were added with labeled internal standard, and proteins were precipitated by acetonitrile and analyzed using liquid chromatography/tandem mass spectrometry. The limit of detection was 0.2 ng/mL. Participants were categorized as nonsmokers if their cotinine levels were ,0.2 ng/mL and as active smokers if their cotinine levels were .15 ng/mL (19) . If their levels were in between, participants were considered to be passive smokers.
participating women or use of thyroid medications according to the questionnaire.
Data on the weight and height of the mothers was derived from the Swedish National Birth Register, and BMI was calculated as weight (kg) divided by squared height (m). Current smoking status of the women based on the questionnaire was defined as follows: nonsmoker, passive smoker (only father or someone else in the household smokes), active smoker (only mother smokes), or active and passive smoker (mother and father and/or someone else in the household smoke).
Statistical analysis
Reference ranges for TSH, FT4, FT3, and TT4 were defined by the 2.5th and 97.5th percentiles after exclusion of TPOAbpositive women and also after exclusion of only TgAb-positive women and after exclusion of both TPOAb-and TGAb-positive women. TSH, TPOAb, and TGAb concentrations were log transformed, and back-transformed values are shown in plots for better interpretation. We used multivariable linear regression analyses, using restricted cubic splines with three knots to assess nonlinearity, to investigate the association of determinants, including cotinine concentrations with maternal serum concentrations of TSH, FT4, FT3, TT4, and TT3. All analyses were adjusted for maternal age, BMI, parity, ethnicity, education level, smoking status, thyroperoxidase and thyroglobulin antibodies and hCG concentrations, child sex, and gestational age. We used multiple imputation by chained equations to handle missing data of covariates with the number of imputation sets as 25 (20) . In addition, complete case sensitivity analyses were performed for all regression models. All statistical analyses were performed using R statistical software version 3.3.2 (R Core Team, Vienna, Austria; packages mice and rms).
Results
Study population
The final study population comprised 2314 women ( Fig. 1) , characteristics of whom are shown in Table 1 . The final study population was recruited at a median gestational age of 10 (2.5th to 97.5th percentile: 6 to 14) weeks, had a mean (SD) age of 31 (4.8) years, and were mostly of Western ethnicity (98%) and self-reported nonsmokers (83%). Of the total study population, 10.9% were TPOAb positive (n = 252) and 8.5% were TgAb positive (n = 197), and of the women positive for TPOAbs or TgAbs, only 24.3% were positive for both antibodies (81 of 333).
Reference ranges of thyroid function
The reference ranges for TSH differed considerably according to the exclusion of TPOAb-positive and/or TgAbpositive women (Table 2 ). Without exclusion of thyroid antibody-positive women, the TSH reference range was 0.12 to 4.24, whereas after exclusion of TPOAb-positive women, the reference range was 0.11 to 3.48. After solely excluding TgAb-positive women, the reference range was 0.11 to 3.73, and additional exclusion of TGAb-positive women on top of excluding TPOAb-positive women hardly changed the TSH reference range. The reference range was 11.6 to 19.4 for FT4, 3.72 to 5.92 for FT3, 82.4 to 166.2 for TT4, and 1.28 to 2.92 for TT3, and these reference ranges did not substantially differ after exclusion of thyroid antibody-positive women (Table 2) .
Thyroid function determinants
Both active and passive smokers (defined by questionnaires) had a lower TSH but higher FT3 and TT3 levels, whereas no association was observed between Tables 2 and 3) . Compared with median values, a lower BMI was associated with a lower TSH and FT4, whereas a higher BMI was associated with a higher TT4, a higher FT3, and a higher TT3 (Figs. 2 to 6) . A later gestational age was associated with a lower FT4 and a lower FT3 but a higher TT4 and a higher TT3 (Figs. 2 to 6 ). Results of complete case sensitivity analyses were largely the same (data not shown).
Discussion
To our knowledge, this is the first large, prospective, population-based study to determine reference ranges for a wide range of thyroid function tests during early pregnancy (median gestational age of 10 weeks) while also studying the role of TPOAbs and TgAbs and identifying various gestational thyroid function determinants. Our results show that the exclusion of TgAb-positive women on top of TPOAb-positive women hardly affects the reference ranges of thyroid function. Also, we further quantified the effects of various determinants on a wide variety of thyroid function tests during pregnancy, including TT3 and FT3 concentrations. Moreover, we
showed that a higher exposure to (secondhand) tobacco smoke, as assessed by serum cotinine concentration or based on questionnaire data, for the first time in this context, to our knowledge, is associated with a lower TSH and a higher free and total T3 concentration. For the correct interpretation of thyroid function tests during pregnancy, practically all international guidelines recommend the calculation of population-specific reference ranges in a healthy population, free of major thyroid-interfering factors such as thyroid-interfering drug use or thyroid autoimmunity (3, 4) . For most studies, the latter is defined particularly with TPOAb positivity. Exclusion of TPOAb-positive women considerably lowers the upper limit of the reference range, particularly for TSH, but the role of TgAbs in calculating reference ranges has been understudied (5, 8, (21) (22) (23) (24) . In this study, we found that dual thyroid antibody positivity occurred in only 5% of all women and in 34.8% of all antibody-positive women. Despite this relatively low overlap, the additional exclusion of TgAb-positive women after the exclusion of TPOAb-positive women hardly affected the reference ranges. This lack of a change in the reference ranges is likely due to the fact that TPOAbs are a more specific marker for thyroid autoimmunity than TgAbs. These results endorse the majority of reference ranges published so far, which are predominantly based on the exclusion of only TPOAb-positive women and provide additional knowledge for future studies.
Although smoking is a known determinant of thyroid function (12) , there is a lack of knowledge on the mechanisms implicated in humans and the different levels at which thyroid interference could occur. Animal studies show that nicotine can increase type 2 deiodinase activity in cultured rat brain glial cells (11) . In addition, thiocyanate (a toxin in cigarette smoke) is a known sodium iodide-symporter inhibitor (25) . Its exposure may result in intrathyroid iodine depletion, subsequent mild thyroid autonomy, and increased thyroid nodularity (12, 13, 26) . Lower intrathyroidal iodine concentration has been shown to result in an increased production of T3 over T4 by the gland itself (27) . Alternatively, smoking might also increase thyroid hormone concentrations through activation of the sympathetic nervous system (12) or via a direct toxic effect on the thyroid gland (28) . To our knowledge, the current study is the first to show that (secondhand) exposure to tobacco smoke during pregnancy, as assessed by serum cotinine concentrations, is associated with a lower TSH concentration, a higher FT3 and TT3 concentration, and a lower FT4/ FT3 ratio. These results are in line with experimental studies suggesting that the effects of smoking result principally through inhibition of iodine uptake and increased deiodinase type 2 expression. Interestingly, our results remained the same when using the questionnaire-derived smoking status compared with cotinine concentrations. This result indicates that any bias or measurement error in self-reported smoking data has a minimal effect on this association. Because measurement of T3 is required for evaluation of subnormal TSH concentrations or nodular goiter during pregnancy, these data can prove useful for interpreting borderline T3 concentrations (3) . Further studies are needed to investigate whether the explained effects of smoking might contribute to the mechanisms associated with adverse effects of smoking on pregnancy and child outcomes and whether measurement of T3 provides an added value for the diagnosis and management of thyroid dysfunction during pregnancy.
Because, to our knowledge, data on gestational FT3 or total T3 are sparse (23, 29, 30) , the results of the current study provide new insights into physiological changes of the thyroid axis during pregnancy. We show that a lower BMI is associated with a lower FT3 but a higher FT4, which is in line with studies in humans and animals showing that higher concentrations of leptin lead to a higher conversion of T4 to T3 and to an increased heat production and energy expenditure (10, 31) . Interestingly, different associations were identified for the total instead of free thyroid hormone concentrations. A higher BMI was associated with both higher TT3 and TT4, suggesting that a higher fat mass is associated with higher concentrations of thyroid hormone binding globulins, particularly thyroxine binding globulin (32) . Similarly, the positive association of gestational age with TT4 and TT3 could be explained via the wellcharacterized increase in thyroxine binding globin throughout gestation (1) . Regarding the socioeconomic Figure 7 . The association of maternal serum cotinine concentrations (ng/mL) with levels of TSH, FT4, and FT3. Plots are based on a multivariable linear regression model adjusted for maternal age, BMI, gestational age, parity, ethnicity, education level, child sex, thyroperoxidase and thyroglobulin antibodies, and hCG.
determinants, both FT3 and TT3 decreased with a higher level of education, indicating that also factors other than BMI and smoking behavior affect thyroid physiology during pregnancy.
In the current study, we were able to define reference ranges and study the determinants for a wide range of thyroid function tests in a large population of healthy women during early pregnancy using detailed data, including both TPOAbs and TgAbs, cotinine concentrations, and potential confounders, including hCG. However, a limitation of this study is that most mothers were Swedish, which could limit the extrapolation of results to other ethnicities or populations. Another potential limitation might be that we did not measure thyroxine binding globulin. In addition to this, measurements of FT4 and FT3, due to alterations in thyroid hormone binding proteins, are assay dependent, and although the interindividual variability of FT4 and FT3 in this study is not affected because the same assay is used for the measurements of all participants, this could affect the generalizability of our results when other assays are used. In addition, due to the observational nature of this study, the causality within studied associations remains unclear, and possible effects of residual confounding, mainly due to the cross-sectional design, cannot be ruled out.
In conclusion, we report the reference ranges of thyroid function during pregnancy, and we show that the calculated reference ranges after exclusion of TPOAb-positive but not TgAb-positive pregnant women are valid and similar to the reference range after additional exclusion of TgAb-positive women. We further show that exposure to tobacco smoke, including secondhand smoke, is associated with considerable changes in thyroid function following a dosedependent effect, and we identified and quantified determinants such as BMI and gestational age for TSH, FT4, TT4, FT3, and TT3 concentrations.
